Pharmaterials Microdosing Service

Microdosing involves administering a very small dose, normally 1/100th of the predicted effective dose, in order to determine the pharmacokinetics of the compound.  This can be done at early stages in development as the safety profile for human volunteers is much improved.

For companies wishing to prepare solid microdose formulations for Phase 0 studies, Pharmaterials has great expertise in formulation of 10-100 microgram dosage forms.